New hope for advanced liver cancer: experimental combo therapy enters trials
NCT ID NCT07479485
First seen Mar 20, 2026 · Last updated May 25, 2026 · Updated 10 times
Summary
This early-stage trial tests a new drug called MRG006A combined with standard immune-boosting and targeted therapies for people with advanced liver cancer that cannot be removed by surgery. The study aims to find the safest dose and check if the combination shrinks tumors. About 160 adults with a life expectancy of at least 3 months and a specific tumor marker (GPC3) will participate.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing You An Hospital, Capital Medical University
Beijing, Beijing Municipality, 100000, China
Contact
-
Henan Cancer Hospital
Zhengzhou, Henan, 450003, China
-
Lishui Central Hospital
Lishui, Zhejiang, 323000, China
Contact
-
Mengchao Hepatobiliary Hospital of Fujian Medical University
Fuzhou, Fujian, 350001, China
Contact
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
Contact
-
The Ethics Committee of Cancer Hospital Chinese Academy of Medical Sciences.
Beijing, Beijing Municipality, 100021, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital With Nanjing Medical University
Nanjing, Jiangsu, 210006, China
Contact
-
Tianjin Cancer Hospital Airport Hospital
Tianjin, Tianjin Municipality, 300308, China
Contact
Conditions
Explore the condition pages connected to this study.